or Try an Advanced Search...

    Disorders Stocks List

    Symbol Grade Name % Change
    PTPI F Petros Pharmaceuticals, Inc. -12.31
    MYMD F MyMD Pharmaceuticals, Inc. -9.87
    ELYM B Eliem Therapeutics, Inc -2.44
    CGTX C Cognition Therapeutics, Inc. -1.52
    OMER D Omeros Corporation -0.71
    REGN C Regeneron Pharmaceuticals, Inc. -0.65
    IBIO C iBio, Inc. 0.00
    PHAT D Phathom Pharmaceuticals, Inc. 0.19
    ONCO F Onconetix, Inc. 0.36
    BAX F Baxter International Inc. 0.54
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Medicine Biopharmaceutical Biotechnology Chronic Pain Clinical Research Cognitive Disorders Immunology Infectious Diseases Inflammation Macular Degeneration Medication Men's Health Ophthalmology Pain S&P 500 Urology Acid Addiction Age Related Diseases Aging Associated Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

    Symbol Grade Name Weight
    IBB C iShares Nasdaq Biotechnology Index Fund 8.39
    IBBQ B Invesco Nasdaq Biotechnology ETF 8.22
    BBH B Market Vectors Biotech ETF 7.93
    PJP A PowerShares Dynamic Pharmaceuticals 5.89
    BIB C ProShares Ultra Nasdaq Biotechnology 5.73
    View all Disorders ETFs...
    Compare ETFs
    Compare IBB to BBH Compare IBBQ to BBH Compare IBBQ to PJP

        Disorders Stocks Recent News

        Date Stock Title
        May 15 OMER Omeros Corporation (OMER) Q1 2024 Earnings Call Transcript
        May 15 OMER Omeros Corporation Reports First Quarter 2024 Financial Results
        May 15 BAX Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
        May 15 PHAT Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
        May 14 OMER Omeros Q1 2024 Earnings Preview
        May 14 REGN Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)
        May 14 BAX Baxter's (BAX) Clinolipid Gets FDA's Expanded Indication
        May 14 REGN Evercore says biotech ‘winter is finally thawing’
        May 13 IBIO iBio reports Q3 results
        May 13 IBIO iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
        May 13 BAX Baxter's Clinolipid gets FDA approval for use in infants
        May 13 PHAT Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q1 2024 Earnings Call Transcript
        May 13 REGN Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
        May 13 REGN Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
        May 13 BAX (BAX) - Analyzing Baxter Intl's Short Interest
        May 13 BAX Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
        May 13 REGN Pipeline Moves: Phase III completion for Corcept’s relaorilant
        May 13 REGN Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
        May 11 PHAT Phathom Pharmaceuticals, Inc. (PHAT) Q1 2024 Earnings Call Transcript
        May 11 BAX Baxter International's (NYSE:BAX) Dividend Will Be $0.29
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Medicine Biopharmaceutical Biotechnology Chronic Pain Clinical Research Cognitive Disorders Immunology Infectious Diseases Inflammation Macular Degeneration Medication Men's Health Ophthalmology Pain S&P 500 Urology Acid Addiction Age Related Diseases Aging Associated Diseases
        Disorders

        Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

        More about Disorders
        Browse All Tags